Synthesis of Commercial Phosphodiesterase(V) Inhibitors

@article{Dunn2005SynthesisOC,
  title={Synthesis of Commercial Phosphodiesterase(V) Inhibitors},
  author={P. Dunn},
  journal={Organic Process Research & Development},
  year={2005},
  volume={9},
  pages={88-97}
}
  • P. Dunn
  • Published 2005
  • Chemistry
  • Organic Process Research & Development
The literature syntheses (including patents) of three commercial phosphodiesterase(V) (PDE5) inhibitors (sildenafil, vardenafil, and tadalafil) are reviewed with particular emphasis on large-scale manufacture. For each of these compounds, some impressive chemical development work has been reported. 
47 Citations

Figures and Tables from this paper

Paper Mentions

Development on the Synthesis of Phosphodieseterase Type 5 (PDE5) Inhibitors
An overview of the synthetic routes to the best selling drugs containing 6-membered heterocycles
Discovery of novel pyrazolopyrimidinone analogs as potent inhibitors of phosphodiesterase type-5.
...
1
2
3
4
5
...

References

SHOWING 1-2 OF 2 REFERENCES
Chinese Patent CN 99 - 111153 ,
  • 2001
World Patent , WO 04 / 011463 . Scheme 14 . Building blocks for tadalafil Scheme 15